US stock · Healthcare sector · Medical Distribution
Company Logo

Cardinal Health, Inc.

CAHNYSE

57.74

USD
+0.63
(+1.10%)
Pre Market
-16.87P/E
11Forward P/E
-0.65P/E to S&P500
15.730BMarket CAP
3.44%Div Yield
Upcoming Earnings
3 Aug-8 Aug
Shares Short
5/13/22
6.77M
Short % of Float
2.86%
Short % of Shares Outs.
2.48%
% Held by Insiders
0.44%
% Held by Institutions
89.54%
Beta
0.83
PEG Ratio
3.03
52w. high/low
64.53/45.85
Avg. Daily Volume
2.79M
Return %
Stock
S&P 500
1 year
4.04
(6.01)
3 years
25.55
39.24
5 years
(21.18)
63.25
Scale: |
High
Low
76.15
56.41
62.25
27.79
39.87
24.87
39.29
29.69
47.06
37.53
44.49
36.91
67.75
41.06
83.40
63.06
91.91
74.76
89.97
62.70
84.88
54.66
75.75
42.17
56.88
41.03
60.69
39.05
62.96
45.85
64.53
48.42
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Revenue per share
219.93
254.30
278.28
274.53
294.45
311.74
296.46
267.11
308.83
371.70
410.02
437.09
485.11
521.92
556.39
153.55
Earnings per share
4.89
3.63
3.22
1.79
2.75
3.10
0.98
3.42
3.66
4.36
4.06
0.82
4.54
(12.61)
2.09
(4.76)
FCF per share
2.19
3.17
2.89
5.23
3.16
2.65
4.49
6.67
6.75
7.66
2.51
7.62
7.98
5.41
6.95
(1.72)
Dividends per share
0.37
0.48
0.56
0.71
0.79
0.87
1.04
1.22
1.39
1.57
1.82
1.86
1.92
1.94
1.96
0.47
CAPEX per share
0.91
1.05
1.49
0.71
0.84
0.76
0.57
0.73
0.90
1.42
1.22
1.23
1.09
1.28
1.37
0.28
Book Value per sh.
21.50
20.59
21.67
24.32
15.14
16.95
18.31
17.52
19.28
19.13
20.68
21.75
20.20
21.60
6.13
6.13
Comm.Shares outs.
395
358
358
359
349
345
341
341
332
327
317
313
300
293
292
292
Avg. annual P/E ratio
13.9
13.8
10.0
19.0
15.4
13.4
51.4
21.2
23.2
17.8
17.7
69.8
10.6
(4.1)
26.0
(11.7)
P/E to S&P500
0.8
0.6
0.1
0.9
0.9
0.9
3.0
1.2
1.2
0.8
0.7
2.8
0.4
(0.1)
0.9
(0.4)
Avg. annual div. yield
0.5%
1.0%
1.7%
2.1%
1.9%
2.1%
2.1%
1.7%
1.6%
2.0%
2.5%
3.3%
4.0%
3.8%
3.6%
0.8%
Revenue (m)
86,852
91,091
99,512
98,503
102,644
107,552
101,093
91,084
102,531
121,546
129,976
136,809
145,534
152,922
162,467
44,836
Operating margin
1.6%
2.3%
1.9%
1.3%
1.5%
1.7%
1.0%
2.1%
2.1%
2.0%
1.6%
0.1%
1.4%
(2.7)%
0.3%
(0.2)%
Depreciation (m)
322
381
399
254
313
325
397
459
451
641
717
1,032
1,000
913
783
181
Net profit (m)
1,931
1,301
1,152
642
959
1,069
334
1,166
1,215
1,427
1,288
256
1,363
(3,696)
611
(1,391)
Income tax rate
32.9%
32.5%
31.4%
51.6%
36.4%
37.0%
62.3%
35.3%
38.4%
37.1%
32.7%
213.6%
22.0%
2.1%
(89.5)%
(914.6)%
Net profit margin
2.2%
1.4%
1.2%
0.7%
0.9%
1.0%
0.3%
1.3%
1.2%
1.2%
1.0%
0.2%
0.9%
(2.4)%
0.4%
(3.1)%
Working capital (m)
3,404
3,085
3,808
4,399
3,381
2,946
3,336
3,180
2,824
4,509
2,255
7,124
1,660
1,638
2,325
3,424
Long-term debt (m)
2,600
3,457
3,687
3,280
1,896
2,175
2,418
3,686
3,171
5,211
4,952
9,068
8,012
7,579
6,765
5,365
Equity (m)
8,491
7,377
7,748
8,725
5,276
5,849
6,244
5,975
6,401
6,256
6,554
6,808
6,059
6,328
1,789
1,791
ROIC
13.1%
11.2%
9.9%
4.5%
12.1%
11.9%
3.8%
11.1%
11.9%
11.9%
9.9%
(0.6)%
9.3%
(20.5)%
5.5%
(6.0)%
Return on capital
10.0%
8.4%
8.1%
5.0%
8.0%
7.8%
4.2%
7.5%
8.1%
8.1%
6.2%
0.2%
5.1%
(8.6)%
1.2%
(0.2)%
Return on equity
22.7%
17.6%
14.9%
7.4%
18.2%
18.3%
5.3%
19.5%
19.0%
22.8%
19.7%
3.8%
22.5%
(58.4)%
34.2%
(77.7)%
Plowback ratio
92.5%
86.7%
82.6%
60.6%
71.4%
71.9%
(5.7)%
64.4%
62.1%
64.1%
55.2%
(127.0)%
57.7%
115.4%
6.2%
109.8%
Div.&Repurch./FCF
375.9%
99.2%
15.6%
23.6%
43.6%
77.5%
44.5%
37.8%
63.6%
46.4%
147.7%
47.4%
49.2%
- -
38.1%
- -
Capital Structure
3 Feb · 2022 | Q3
All numbers in millions
Total liabilities
$ 42,678
Total assets
$ 43,680
Long-term debt
$ 5,342
Cash and equiv.
$ 3,161
Goodwill
$ - -
Retained earnings
$ 1,524
Common stock
279
Enterprise Value
$ 17,911
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
2,531
2,771
3,407
Receivables
8,448
8,264
9,103
Inventory
12,822
13,198
14,594
Other
1,946
1,947
4,820
Current assets
25,747
25,940
31,048
Acc. Payable
21,535
21,374
23,700
Debt due
452
10
871
Other
2,122
2,231
3,053
Current liabilities
24,109
23,615
27,624
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
(72.40)%
(13.68)%
(2.37)%
Cash flow
(124.69)%
(32.51)%
6.63%
Earnings
(327.66)%
(95.73)%
(22.45)%
Dividends
(76.27)%
(19.41)%
(2.73)%
Book value
0.11%
(19.54)%
(7.66)%
Insider Trading
Type
Shares
Date
Hollar Jason M.
InKind
3,392
05/15/22
Scarborough Dean A
Award
456
04/14/22
Mayer Jessica L
InKind
1,332
03/15/22
Rice Brian S
InKind
1,960
02/15/22
Scarborough Dean A
Award
550
01/13/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
36,689
37,341
39,735
39,157
152,922
2021
42,586
39,065
41,541
39,275
162,467
2022
37,353
43,968
45,457
44,836
171,614
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
2.24
(16.80)
0.75
1.19
(12.61)
2021
0.40
(0.87)
2.15
0.41
2.09
2022
0.65
0.93
0.17
(4.76)
(3.02)
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.48
0.50
0.48
0.48
1.94
2021
0.48
0.50
0.49
0.49
1.96
2022
0.48
0.51
0.48
0.47
1.93
Company Description
Sector:
Healthcare
Industry:
Medical Distribution
CEO:
Mr. Michael Kaufmann
Full-time employees:
46,354
City:
Dublin Ohio
Address:
7000 Cardinal Pl
IPO:
Sep 7, 1994
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.